Does TAPENTADOL Cause Dysarthria? 37 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Dysarthria have been filed in association with TAPENTADOL (Nucynta). This represents 0.1% of all adverse event reports for TAPENTADOL.
37
Reports of Dysarthria with TAPENTADOL
0.1%
of all TAPENTADOL reports
3
Deaths
12
Hospitalizations
How Dangerous Is Dysarthria From TAPENTADOL?
Of the 37 reports, 3 (8.1%) resulted in death, 12 (32.4%) required hospitalization, and 1 (2.7%) were considered life-threatening.
Is Dysarthria Listed in the Official Label?
Yes, Dysarthria is listed as a known adverse reaction in the official FDA drug label for TAPENTADOL.
What Other Side Effects Does TAPENTADOL Cause?
Death (11,560)
Toxicity to various agents (9,617)
Overdose (5,843)
Drug abuse (1,566)
Drug dependence (1,019)
Drug withdrawal syndrome neonatal (945)
Accidental overdose (693)
Drug ineffective (633)
Pain (436)
Nausea (434)
What Other Drugs Cause Dysarthria?
OLANZAPINE (900)
QUETIAPINE (669)
PREGABALIN (618)
AMLODIPINE (553)
GABAPENTIN (548)
METFORMIN (540)
METHOTREXATE (536)
DIAZEPAM (512)
ASPIRIN (495)
LORAZEPAM (483)
Which TAPENTADOL Alternatives Have Lower Dysarthria Risk?
TAPENTADOL vs TAPINAROF
TAPENTADOL vs TARCEVA
TAPENTADOL vs TARLATAMAB
TAPENTADOL vs TARLATAMAB-DLLE
TAPENTADOL vs TASIGNA